Technopath Clinical Diagnostics Introduces the First Unified, Purpose-Built Quality Control (QC) Platform Providing a Higher Level of Confidence

Technopath Clinical Diagnostics

Technopath Clinical Diagnostics Introduces the First Unified, Purpose-Built Quality Control (QC) Platform Providing a Higher Level of Confidence in the Precision and Accuracy of Patient Sample Results

 

PR85863

 

NEW YORK and BALLINA, Ireland, Oct. 1, 2020 /PRNewswire=KYODO JBN/ --

 

- IAMQC Infinity(TM) is the first Software-as-a-Service (SaaS) platform for

clinical laboratories to bring together worldwide peer comparisons, advanced QC

analytics, proficiency testing data, and daily QC data management functions in

real-time on one unified platform

 

- IAMQC Infinity empowers frontline laboratory staff to spend less time on

false-positive QC flags while concentrating on tests that require their attention

 

- IAMQC web-based technology, unified with Infinity's open system flexibility

to optimize all QC data generated in the lab, delivers higher confidence in

analytical testing methods while significantly reducing time, effort, and costs

 

Technopath, a leading global provider of SaaS-based QC data management

solutions and third-party laboratory quality controls, today introduced IAMQC

Infinity to support the growing need from modern laboratories for robust

management of overall quality control and proficiency testing. Based on these

challenges, IAMQC Infinity significantly improves operational efficiencies

through a unified QC technology platform bringing people, systems, and data

together to form a collaborative, efficient, and effective ecosystem that

analyses QC results in real-time.

 

Laboratory testing of patient samples can be complicated, and QC represents one

of the most important impacts on laboratory testing as it ensures both the

precision and accuracy of patient sample results. The integrity of quality control

samples is essential, and IAMQC Infinity delivers higher confidence in analytical

testing methods satisfying the varying QC requirements in individual laboratories.

 

"With quality control data growing, and the management of that QC data

increasing in complexity, our focus is on innovating and developing the

best-in-class QC solutions platform for the laboratory community," said Malcolm

Bell, CEO and founder of Technopath. "Modern laboratories have many constraints

in their daily processes underscored by a rapidly changing requirement to

quickly review current or historical data by lab, department, instrument or

test. Optimizing and managing QC data is imperative, and the Infinity platform

is purpose-built to capture and evaluate these constantly evolving data types

allowing laboratorians to have greater confidence that their patient testing is

producing accurate results."

 

IAMQC Infinity is an easy-to-use, cost-effective platform built on a highly

scalable SaaS architecture, allowing users to automate, centralize, standardize

and improve QC processes, eliminating the need for manual entry by skilled

laboratory technologists. Infinity brings all the key elements of powerful

cloud-based software tools to analyze QC results into one web-based solution.

With pressures increasing on the laboratory to turn around fast, accurate

patient results, the new platform will include three feature-rich tools

designed to facilitate the entire quality control process from end to end:

 

IAMQC Peer - an innovative, real-time, peer comparison helping laboratories

validate their QC protocols including the proliferation of new instruments,

methods, and tests.

 

IAMQC Daily - a comprehensive internal quality control software that applies

Westgard or any user-defined QC rules to individual QC results.

 

IAMQC Expert - an interactive system that empowers frontline laboratory staff

to select QC rules, reduce unnecessary repeats, and make meaningful QC decisions.

 

Modern laboratories are becoming increasingly reliant on real-time, independent

QC data to make timely and informed decisions. The latest IAMQC updates bring

more substantial analytics capabilities, allowing laboratories to turn data

points into meaningful insights. The system is easy to set up, and removes

obstacles such as server installation, based on customer feedback including

Northwell Hospital, New York's largest healthcare provider.

 

IAMQC Infinity platform is rolling out globally in two phases:

 

Phase 1 rollout is now live and includes the critical functions required for

IAMQC Daily such as rule evaluation, tracking of actions and comments, and

custom rule set configuration.

 

Phase 2 will deploy several solutions that include built-in peer comparison

functionality and reports and advanced QC analysis tools such as Total Error

calculations and problem solver wizards. These follow up releases will be

scheduled to launch in Q2, 2021.

 

About IAMQC

[https://www.technopathclinicaldiagnostics.com/products/informatics-solutions/ov

erview-software-solutions/ ]

 

For more about Technopath please visit:

https://www.technopathclinicaldiagnostics.com/about/our-company/ 

 

Logo - https://mma.prnewswire.com/media/1165846/Technopath_Logo.jpg 

 

For Media:

Sunny Uberoi

Corporate Communications

Telephone: +1-917-747-2018

Email: sunny@166media.com

 

For Business Development:

Conor Connolly

VP Commercial, Technopath Clinical Diagnostics

Email: conor.connolly@technopathcd.com

 

For Business Development USA:

Todd Leger

CEO Technopath Clinical Diagnostics USA Inc

Email: todd.leger@technopathusa.com

 

For Marketing & Communications:

Len Lloyd

Director Marketing, Technopath Clinical Diagnostics

Email: len.lloyd@technopathcd.com

 

Source: Technopath Clinical Diagnostics

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中